01
Our Mission
At VerAvanti, our mission is to advance medical diagnostics and treatment with precise, single-use endoscopic solutions focused on patient safety, efficiency, and diagnostic accuracy. Recognizing the limitations of traditional side-view imaging and reusable scopes, we collaborated with the University of Washington to develop our patented SaFE technology. Each step has brought us closer to creating a product that meets the needs of modern healthcare.
As we aim for FDA approval in 2025, VerAvanti is preparing to expand production and introduce our diagnostic solutions worldwide. Committed to ongoing innovation, we aim to improve healthcare standards by making procedures safer, faster, and more effective for both patients and providers.
02
The Timeline
1
Foundational Research and Collaboration
Laying the groundwork for groundbreaking technology.
Initial research began in collaboration with the University of Washington, forming the basis for our fiber-optic endoscopy innovations.
2
Prototype Testing and Validation
Ensuring safety and effectiveness through testing.
Early prototypes underwent rigorous lab and clinical testing, validating our imaging excellence.
3
Securing 50+ Patents
Protecting our technology through comprehensive patents.
We secured over 50 patents in the U.S.A, reinforcing VerAvanti’s commitment to advancing exclusive, protected innovations.
5
Final Production Model Established
Refining the design for scalability and precision.
The production model is under finalization, with in-house manufacturing processes set up to maintain quality and precision at scale.
6
FDA Approval and Market Launch
Bringing VerAvanti’s innovations to healthcare providers.
With FDA approval anticipated by 2025, VerAvanti is poised to launch its technology globally, redefining standards in diagnostics and treatment.
03
Leadership
Gerald McMorrow
Founder and CEO
Luis Savastano
Chief Medical Officer
Jason Capodanno
Chief Operating Officer
Clinical Advisors
Patrick McVeigh, MD
MD
Mark Reisman
Clinical Professor of Medicine
William Lombardi
Associate Clinical Professor of Medicine
John Petersen
Director of Cardiovascular Research
Gerald McMorrow
Chairman of the Board
Fred Moll
M.D., Founder and CEO of Auris Health
David C. Auth
Ph.D, Affiliate Professor of Bioengineering
Michael Moyer
Board Member